Caffeine and the analog CGS 15943 inhibit cancer cell growth by targeting the phosphoinositide 3-kinase/Akt pathway.Effects of CGS 15943, a nonxanthine adenosine antagonist, on behavior in the squirrel monkey.Discriminative effects of CGS 15943, a competitive adenosine receptor antagonist, in monkeys: comparison to methylxanthines.Biochemical characterization of the triazoloquinazoline, CGS 15943, a novel, non-xanthine adenosine antagonist.CGS 15943, a nonxanthine adenosine receptor antagonist: effects on locomotor activity of nontolerant and caffeine-tolerant rats.Comparison of CGS 15943, ZM 241385 and SCH 58261 as antagonists at human adenosine receptors.Characterization of the binding of a novel nonxanthine adenosine antagonist radioligand, [3H]CGS 15943, to multiple affinity states of the adenosine A1 receptor in the rat cortex.CGS 15943, an adenosine A2 receptor antagonist, reduces cerebral ischemic injury in the Mongolian gerbil.Do adenosinergic substrates mediate methylxanthine effects upon reinforcement thresholds for electrical brain stimulation in the rat?Effects of a non-xanthine adenosine antagonist, CGS 15943, and a phosphodiesterase inhibitor, Ro 20-1724, in a light/dark test in mice.Discriminative effects of CGS 15943, a competitive adenosine receptor antagonist, have a dopamine component in monkeys.Comparative effects of caffeine and selective phosphodiesterase inhibitors on respiration and behavior in rhesus monkeys.Influence of CGS 15943 A (a nonxanthine adenosine antagonist) on the protection offered by a variety of antiepileptic drugs against maximal electroshock-induced seizures in miceMyocardial adenosine A1 and A2 receptor activities during juvenile and adult stages of development
P921
Q33631453-5FF5A1C9-524C-4D30-9CE1-0AE7002CBBC3Q34344050-651E362B-936E-4F0F-9922-AC6019AC8869Q34379230-152C8A37-9D5E-441F-8217-FFB6FB94EADBQ34559428-68E75B83-6D69-4151-B79D-88D258C1BC0AQ34980523-C05AF4B5-09DB-4306-93B1-68CF8C2C5198Q40975392-F19E7E37-95D8-4FC9-B846-0A50F2B6B43DQ41893090-11DD2649-0C8A-4FB0-881A-93FCE65449D5Q48216955-4DBA9A57-B1B3-46DA-B95D-0DF2FE62CCFEQ48719438-A4F93DA4-4720-42B1-91B0-1781A40C62E7Q51129847-DCF2ACD1-94D5-45C1-8BAB-1973AC80A8A6Q51447030-CB97F6DA-621D-4083-ACEF-C67CF0E1BB79Q52223813-4B5249BD-8C92-4E5A-9C16-C720E279E3ABQ68061825-99888B0A-E275-4D56-95A2-B44B9A8C4D10Q71404878-DE5798E7-BA82-412C-BD43-4BB7660CC625
P921
description
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
CGS 15943
@en
CGS-15943
@de
CGS-15943
@nl
CGS-15943
@ro
CGS-15943
@sh
CGS-15943
@sr
CGS-15943
@vi
type
label
CGS 15943
@en
CGS-15943
@de
CGS-15943
@nl
CGS-15943
@ro
CGS-15943
@sh
CGS-15943
@sr
CGS-15943
@vi
altLabel
C13H8ClN5O
@sr
CGS 15943A
@en
CGS-15943
@en
CGS15943
@en
prefLabel
CGS 15943
@en
CGS-15943
@de
CGS-15943
@nl
CGS-15943
@ro
CGS-15943
@sh
CGS-15943
@sr
CGS-15943
@vi
P129
P592
P6366
P661
P662
P683
P129
P2067
285.041738
P231
104615-18-1
P233
C1=COC(=C1)C2=NN3C(=N2)C4=C(C=CC(=C4)Cl)N=C3N
P234
1S/C13H8ClN5O/c14-7-3-4-9-8(6- ...... 12)13(15)16-9/h1-6H,(H2,15,16)
P235
MSJODEOZODDVGW-UHFFFAOYSA-N
P274
C₁₃H₈ClN₅O
P3117
DTXSID80146617
P592
CHEMBL16687
P6366
2777715061